» Articles » PMID: 21530356

The Long-duration Response to Levodopa: Phenomenology, Potential Mechanisms and Clinical Implications

Overview
Specialty Neurology
Date 2011 May 3
PMID 21530356
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The antiparkinsonian response to levodopa is characterized by an immediate motor improvement lasting hours and a more sustained response lasting days. These two responses have been referred to as the short-duration response (SDR) and the long-duration response (LDR). The LDR represents a substantial component of the clinical effect of levodopa and has been clinically recognized for several decades, but it remains poorly understood. This review will focus on the LDR phenomenology and theories about its origin, with the goal of promoting inquiry into this important but as yet poorly understood aspect of levodopa therapy for PD.

Citing Articles

Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson's disease: a systematic review and meta-analysis.

Kou W, Cai H, Cui Y, Zhu J, Li S, Yang C J Neurol. 2025; 272(2):176.

PMID: 39891751 DOI: 10.1007/s00415-025-12894-8.


Motor learning is modulated by dopamine availability in the sensorimotor putamen.

Muehlberg C, Goerg S, Rullmann M, Hesse S, Sabri O, Wawrzyniak M Brain Commun. 2024; 6(6):fcae409.

PMID: 39584157 PMC: 11582004. DOI: 10.1093/braincomms/fcae409.


Motivational Vigor in Parkinson's Disease Requires the Short and Long Duration Response to Levodopa.

Brissenden J, Scerbak T, Albin R, Lee T Mov Disord. 2023; 39(1):76-84.

PMID: 38062630 PMC: 10842158. DOI: 10.1002/mds.29659.


Clinical characteristics and reaction to dopaminergic treatment of drug-naïve patients with Parkinson's disease in central China: A cross sectional study.

Zeng W, Wang Y, Liu L, Wu Y, Xu Y, Zhai H Heliyon. 2023; 9(7):e18081.

PMID: 37483764 PMC: 10362235. DOI: 10.1016/j.heliyon.2023.e18081.


Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's disease.

Jenner P, Falup-Pecurariu C, Leta V, Verin M, Auffret M, Bhidayasiri R J Neural Transm (Vienna). 2023; 130(11):1337-1347.

PMID: 37210460 PMC: 10645644. DOI: 10.1007/s00702-023-02655-0.